348: Cuts, ousters and drama at the FDA
The Readout Loud
Concerns Over FDA Layoffs and Their Impact on Drug Development
This chapter examines the recent layoffs at U.S. health agencies, particularly the FDA, and their impact on drug development and safety oversight. It highlights concerns from former FDA leadership about the loss of expertise and the need for supportive government policies for pharmaceutical innovation.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
